Form 4: Director Leslie Varon Receives Dentsply Sirona RSU Grant
Statement of Changes in Beneficial Ownership
Director Leslie F. Varon was granted 22,822 restricted stock units in Dentsply Sirona Inc. as part of an equity compensation award.
Summary
- Director Leslie F. Varon acquired 22,822 restricted stock units (RSUs) of Dentsply Sirona Inc. (XRAY) on June 3, 2026.
- The transaction was granted at a price of $0 per share, representing an equity award.
- Following this transaction, the reporting person's total beneficial ownership increased to 80,364 shares of common stock.
- The RSUs are scheduled to vest in full one year from the date of the grant.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.
Positives
- The grant aligns the interests of the director with those of shareholders through equity ownership.
- The increase in beneficial ownership demonstrates a commitment to the company's long-term performance.
Negatives
- None identified.
Risks
- The value of the equity grant is subject to market volatility and the future performance of Dentsply Sirona stock.
Future Outlook
The RSUs will vest in full on June 3, 2027, at which point the restrictions will lapse.
Management Comments
- The grant consists entirely of Restricted Stock Units (RSUs) that vest in full one year from the date of grant.
Industry Context
StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure alignment with shareholder interests in the dental technology and medical device sector.
Comparison to Industry Standards
- The use of one-year cliff vesting for director RSUs is consistent with standard compensation practices among S&P 500 and mid-cap medical device companies.
- The grant size is typical for a director-level equity compensation package in the healthcare equipment industry.
Stakeholder Impact
- Shareholders benefit from the alignment of director incentives with long-term company growth.
Next Steps
- Vesting of the 22,822 RSUs on June 3, 2027.
Key Dates
| Date | Description |
|---|---|
| 06/03/2026 | Date of the RSU grant transaction. |
| 06/05/2026 | Date the Form 4 was filed with the SEC. |
Keywords
Dentsply Sirona, XRAY, Form 4, Insider Trading, Restricted Stock Units, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.